Dan Katz, MD
Emergency Medicine · Los Angeles, CANPI 1922094101
Payments from drug & device makers
Across 6 payments — averaging $20.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bardy Diagnostics, Inc.$47
- Nabriva Therapeutics, PLC$32
- Seqirus USA Inc$26
- Genentech USA, Inc.$15
What the payments were for
- Food & beverage$120100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bardy Diagnostics, Inc. | 2 | $47 |
| Nabriva Therapeutics, PLC | 2 | $32 |
| Seqirus USA Inc | 1 | $26 |
| Genentech USA, Inc. | 1 | $15 |
How this compares
$120 in reported general payments places this provider in the 70th percentile of 6,006 emergency medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 12 | $6,437 |
| PaxlovidNirmatrelvir/Ritonavir | 24 | $1,429 |
| SynthroidLevothyroxine Sodium | 17 | $1,053 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 22 | $684 |
| Cefpodoxime Proxetil | 12 | $453 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $416 |
| Cefdinir | 13 | $345 |
| Azithromycin | 45 | $296 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 23 | $294 |
| Cephalexin | 34 | $226 |
| Doxycycline Hyclate | 28 | $222 |
| Mupirocin | 30 | $189 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $175 |
| Tamsulosin Hcl | 16 | $160 |
| Methylprednisolone | 14 | $119 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Los Angeles
- Anna Ryabets-LienhardLos Angeles$3M
- Luis Abrishamian-GarciaLos Angeles$1M
- David MurrayLos Angeles$269K
- Tzujen TzaoLos Angeles$227K
- Christopher PeabodyLos Angeles$163K
- Robert RodriguezLos Angeles$160K
- Marc FuternickLos Angeles$154K
- Stephen LiuLos Angeles$153K
- Samuel BeckermanLos Angeles$81K
- Jeffrey OvercashChula Vista$31.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.